Pubblicazioni

S.S.D. Microcitemia, anemie congenite e dismetabolismo del ferro

2019

 

2018

2017

 

 

2016

2015

2014

2013

2012

2011

2010

            2009

            2008

            2007

            • Positano V, Pepe A, Santarelli MF, Scattini B, De Marchi D, Ramazzotti A, Forni G, Borgna-Pignatti C, Lai ME, Midiri M, Maggio A, Lombardi M, Landini L. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed. 2007 Oct;20(6):578-90
            • Vichinsky E, Onyekwere O, Porter J, Swerdlow P, Eckman J, Lane P, Files B, Hassell K, Kelly P, Wilson F, Bernaudin F, Forni GL, Okpala I, Ressayre-Djaffer C, Alberti D, Holland J, Marks P, Fung E, Fischer R, Mueller BU, Coates T; Deferasirox in Sickle Cell Investigators. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007 Feb;136(3):501-8
            • Vassanelli A, Lodi G, Forni G, Cabibbo S, Pennisi A, Perseghin P, De Meis I, Messina R, Pani M, Poma R, Guastella G, Lunghi M, Mazzoni A, Capuzzi E, Denti A, Perotti C, Sassi M, Mariano MT, Dal Canton, Multicentric retrospective study on erythroexchange in sikle cell disease. Preliminary rusults. Haematologica. 2007 Oct. 92(3):16:17
            • Porter J, Galanello R, Saglio G, Neufeld EJ, Vichinsky E, Cappellini MD,Olivieri N, Piga A, Cunningham MJ, Soulières D, Gattermann N, Tchernia G,Maertens J, Giardina P, Kwiatkowski J, Quarta G, Jeng M, Forni GL, Stadler M, Cario H, Debusscher L, Della Porta M, Cazzola M, Greenberg P, Alimena G, Rabault B, Gathmann I, Ford JM, Alberti D, Rose C. Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol. 2007 Nov 17

            2006

            • Borgna-Pignatti C, Cappellini MD, DiStefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood, 2006 May 1;107(9):3733-7
            • Marinelli M, Cuneo S, Gianesin B, Lavagetto A, Lamagna M, Oliveri E, Sobrero G, Terenzani L, Forni GL. Non - invasive measurement of iron overload in the human body. IEEE Transactions on Applied Superconductivity, VOL. 16, No. 2, June 2006
            • Piga A, Galanello R, Forni GL,  Cappellini MD, Origa R, Zappu A, Donato G, Bordone E, Lavagetto A, Zanaboni L, Sechaud R, Hewson N, Ford JM, Opitz H, Alberti D. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, im comparison to deferoxamine in thalassemia patients with trasfusional iron overload. Haematologica 2006; 91:873-880
            • R.Galanello, A. Piga, G. L. Forni, Y. Bertran, M. L. Foschini, E. Bordone, G.B. Leoni, A. Lavagetto, A. Zappu, F. Longo, H. Maseruka, N Latham, R. Sechaud, R. Belleli and D. Alberti. Phase II clinical evaluation of deferairox (Exjade®, ICL670), a once-daily oral chelating agent, in paediatric patiens with β-thalassaemia major. Haematologica, 2006; 91:1343-51
            • Marinelli M, Beruto P, Gianesin B, Lavagetto A, Lamagna M, Oliveri E, Saccone ML, Sobrero G, Terenzani L, Forni GL. Whole Liver Iron Overload Measurement by magnetic Iron Detector (MID). A Non Cryogenic Bio-Susceptometer. Blood, Vol. 108, issue 11, Nov 2006
            • E. Vichinsky, O. Onyekwere, J. Porter, P. Swerdlow, J. Eckman, P. Lane, B. Files, K. Hassell, P. Kelly, F. Wilson, F. Bernaudin, G. L. Forni, I.Okpala, C. Ressayre-Djaffer, D. Alberti, J. Holland, P. Marks, E. Fung, R. Fischer, B. U. Mueller and T. Coates for the Deferasirox in Sickle Cell Investigators. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. British Journal of Haematology, 2006: 136, 501-508

            2005

            • Derchi G, Forni GL, Formisano F, Cappellini MD, Galanello R, D'Ascola G, Bina P, Magnano C, Lamagna M. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies Haematologica, 2005 Apr; 90(4):452-8
            • Jambrik Z, Derchi G, Picano E, Ait-Ali L, Forni GL, Bellotti P. Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with  thalassemia major: a long-term follow-up study Echocardiography. 2005 Mar; 22(3):239-44
            • Derchi G, Forni G.L. Therapeutic Approaches to Pulmonary Hypertension in Hemoglobinopathies: efficacy and safety of  sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy Ann. N.Y. Acad. Sci. 1054: 471-475 (2005)
            • Borgna-Pignatti C, Cappellini MD, De Stefano P,  Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A,  Romeo MA, Zhao H, Cnaan A. Survival and complications in thalassemia Ann N Y Acad Sci.2005 Nov; 1054:40-7
            • Forni GL, Ivaldi G Inquadramento diagnostico delle emoglobinopatie alla luce dei flussi migratori Haematolologica vol. 90, suppl. n.4, 52-53  Sept 2005
            • Forni GL L'impiego dell'ICL 670 (deferasirox) nella terapia ferro chelante Haematolologica vol. 90, suppl. n. 4, 71-72 Sept 2005
            • Laura Cemonesi, Gian Luca Forni, Nadia Soriani, Martina Lamagna, Isabella Fermo, Filomena Daraio, Anna Galli, Daniela Pietra, Maurizio Ferrari, Clara Camaschella &  Mario Cazzola. Genetic and clinical heterogeneity of ferroportin disease Br J Haematol. 2005 Dec;131(5):663-70

            2004

            • Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG. Hepatocellular carcinoma in the thalassaemia syndromes Br J Haematol. 2004 Jan;124(1):114-117.
            • G.L. Forni Pseudoxanthoma elasticum and clinical syndromes peculiar to thalassemia In "Clinical Aspects and Therapy of Thalassemia" A.Maggio- A.V. Hoffbrand, Chapter 5, ed. SEU, 2004
            • Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine Haematologica, 2004 Oct; 89(10):1187-93
            • Prati D, Maggioni M, Milani S, Cerino M, Cianciulli P, Coggi G, Forni GL,  Magnano C, Meo A, Gramiglioli R, Rebulla P, Fiorelli G, Cappellini MD; Cooleycare Cooperative Group. Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases Haematologica, 2004 Oct; 89(10):1179-86
            Azioni sul documento